Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.
Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.
Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.
One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:
More top news
Very misty, grey, cool day on Tuesday. Some rain on Wednesday. Frost-free nights in general, but not especially warm by day
Mist at the coast should lift readily this morning, but extensive overnight mist may linger through the south and east of the region
A cold front out in the North Sea is sitting across parts of the region and giving lots of cloud and some patchy rain, especially in the SE